Trial Profile
Clinical trial for pre-exposure prophylaxis for HIV infection toward Tokyo Olympic
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Aug 2022
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 03 Aug 2019 Status changed from recruiting to active, no longer recruiting.
- 15 Mar 2018 Status changed from not yet recruiting to recruiting.
- 30 Jan 2018 New trial record